Clinical Trials of Topical Ruxolitinib in Atopic Dermatitis

Alexandra Golant, MD, highlights the positive clinical data of ruxolitinib, a topical JAK inhibitor used for the treatment of atopic dermatitis.

Related Keywords

, Alexandra Golant , Linda Stein Gold , Stein Gold , Atopic Dermatitis , Sad , Jak Inhibitors , Ruxolitinib , Nonsteroidal Agent , Clinical Trials Of Ruxolitinib ,